Risk factors of postoperative septic cardiomyopathy in perioperative sepsis patients
Conclusion: Endoscopic surgery and SOFA score ≥ 7 during postoperative ICU admission were independent risk factors for SCM within 48 hours postoperatively in patients with perioperative sepsis. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - July 5, 2022 Category: Consumer Health News Source Type: news
Sepsis-Induced Cardiomyopathy Risk May Extend Even Postdischarge Sepsis-Induced Cardiomyopathy Risk May Extend Even Postdischarge
Its impact on mortality, especially when there is right ventricular involvement, can persist after the condition apparently resolves, suggests a meta-analysis.First Look (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - May 18, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
Tips During Contrast Shortage; Cardiologist-Hacker Caught; Cardiomyopathy Genes
(MedPage Today) -- Due to the ongoing shortage of CT contrast media, the American Society of Nuclear Cardiology says to consider SPECT or PET as alternatives for patients scheduled for CT angiography.
While the shortage continues, hospitals can... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - May 17, 2022 Category: Cardiology Source Type: news
May 13 2022 This Week in Cardiology May 13 2022 This Week in Cardiology
Obstructive hypertrophic cardiomyopathy and mavacamten, SGLT2 inhibitors, the triple whammy, espresso, and clinician burnout are the topics John Mandrola, MD, covers in today ’s podcast.theheart.org on Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 13, 2022 Category: Consumer Health News Tags: Cardiology Commentary Source Type: news
Has cardiac MRI reached its diagnostic potential?
Cardiac MRI has overcome issues that limited its use in the past. But challenge...Read more on AuntMinnie.comRelated Reading:
Cardiac MRI predicts heart failure risk in cardiomyopathy patients
Myocarditis induced by COVID-19-vaccine milder than that caused by other factors
Myocarditis linked to COVID-19 affects small number of athletes
Cardiac MRI is 'technique of choice' for imaging suspected heart tumors
New MRI method detects heart injuries in COVID-19 patients (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2022 Category: Radiology Source Type: news
FDA Approves Camzyos (mavacamten) for the Treatment of Symptomatic NYHA Class II-III Obstructive Hypertrophic Cardiomyopathy
PRINCETON, N.J.--(BUSINESS WIRE)-- Bristol Myers Squibb (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) approved Camzyos (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules) for the treatment of adults with symptomatic New... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - April 30, 2022 Category: Drugs & Pharmacology Source Type: news
FDA OKs heart drug at center of $13 billion deal for Peninsula company
A heart drug at the center of Bristol-Myers Squibb Co.'s $13 billion acquisition of a Peninsula company 18 months ago was approved Thursday by federal regulators.
Mavacamten, which will be branded as Camzyos and sold for $89,500 a year after the Food and Drug Administration's approval, is designed to treat adults with symptomatic obstructive hypertrophic cardiomyopathy, or HCM, a genetic heart condition.
HCM makes the heart wall thicken so the heart pumps blood less efficiently. The condition,… (Source: bizjournals.com Health Care News Headlines)
Source: bizjournals.com Health Care News Headlines - April 29, 2022 Category: Health Management Authors: Ron Leuty Source Type: news
Cardiac Myosin Inhibitor Gets FDA's Blessing for Obstructive HCM
(MedPage Today) -- The FDA approved mavacamten (Camzyos) for the treatment of obstructive hypertrophic cardiomyopathy (HCM) in people with New York Heart Association class II-III symptoms -- but on the condition it would only be available through... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 29, 2022 Category: Cardiology Source Type: news
Slash health: 'I was fortunate. I didn’t die' - guitarist on drug-induced heart disease
LEGENDARY guitarist Slash, born Saul Hudson, made his name as part of hard rock band Guns N' Roses. Having reached the height of his fame in the 1990s, Slash struggled with both drugs and alcohol addiction, a habit that would severely damage his long-term health as back in 2001, he was diagnosed with cardiomyopathy, a form of congestive heart failure. (Source: Daily Express - Health)
Source: Daily Express - Health - April 22, 2022 Category: Consumer Health News Source Type: news
ACC: Mavacamten Cuts Need for Surgery in Hypertrophic Cardiomyopathy
MONDAY, April 11, 2022 -- For patients with obstructive hypertrophic cardiomyopathy (HCM), mavacamten improves symptoms and reduces the need for septal reduction therapy (SRT), according to a study presented at the annual meeting of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 11, 2022 Category: Pharmaceuticals Source Type: news
AI mines MRI to predict future death from cardiac arrest
An artificial intelligence (AI) algorithm can predict from a patient's raw M...Read more on AuntMinnie.comRelated Reading:
Cardiac MRI predicts heart failure risk in cardiomyopathy patients
CAC scores predict cardiac risk in patients with high cholesterol
Does higher risk of heart disease always translate to cardiac events?
AI can add value in all parts of MR imaging chain (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - April 7, 2022 Category: Radiology Source Type: news
Migraines May Affect Outcomes in Takotsubo Cardiomyopathy
TUESDAY, April 5, 2022 -- Patients with Takotsubo cardiomyopathy (TCM), which is typically due to a neurocardiogenic mechanism, with migraine have lower odds of mortality and acute complications compared with TCM patients without migraine, according... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 5, 2022 Category: Pharmaceuticals Source Type: news
Baby girl with rare heart condition finally receives a successful transplant
Elodie Baker, who is under one year old, received a successful heart transplant on March 27. She was diagnosed with dilated cardiomyopathy, a rare but dangerous heart condition last year. (Source: the Mail online | Health)
Source: the Mail online | Health - April 4, 2022 Category: Consumer Health News Source Type: news
Mavacamten Controlled Hypertrophic Cardiomyopathy for > 1 Year Mavacamten Controlled Hypertrophic Cardiomyopathy for > 1 Year
Open-label mavacamten for a median of 62 weeks in patients with symptomatic obstructive hypertrophic cardiomyopathy showed ongoing safety and efficacy.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 4, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM VALOR-HCM: Novel Drug May Delay, Avert Invasive Therapy in OHCM
A medical alternative to highly invasive septal reduction therapy for patients with obstructive hypertrophic cardiomyopathy and symptoms despite standard meds? Perhaps, a randomized trial suggests.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 2, 2022 Category: Cardiology Tags: Cardiology News Source Type: news
